Product Name: Pyridoclax
 CAT#: A-1382

Request Pyridoclax
 Synonym: Pyridoclax,MR-29072

Pyridoclax Chemical Structure
Pyridoclax chemical structure


5 stars, based on 879461 reviews
$1 Order now!
IUPAC/Chemical name:

Price of Pyridoclax

We offer a substantial discount on larger orders,
please inquire via sales@activebiochem.com
or Fax: 1-201-884-1288 (USA Fax#)


Biological Activity
Pyridoclax(MR-29072) is a potent Mcl-1 inhibitor with Kd value of 25 nM.
Target: Mcl1 inhibitor
Pyridoclax is able to disrupt BimL/Mcl-1 interaction in whole living cells. Pyridoclax strongly sensitizes ovarian cancer chemoresistant IGROV1-R10 cells to Bcl-xL targeting siRNA, their combination leading to massive apoptosis. Neither ABT-737 nor Pyridoclax induced cell death as single agents, whereas their combination led to massive apoptotic cell death in both IGROV1-R10 and SKOV3 chemoresistant ovarian cancer cell lines.
Technical Data

Formula:C29H22N4
CAS#:
M.Wt:426.51
Solubility:Soluble in DMSO
Purity: >99%
Storage Conditions: Room temperature, or -20ºC for 3 years.

Reference
http://www.ncbi.nlm.nih.gov/pubmed/25585174
Apoptosis control defect such as the deregulation of Bcl-2 family members expression is frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in absence of chemotherapy. Whereas Bcl-xL inhibitors are now available Mcl-1 inhibition, required to sensitize cells to Bcl-xL-targeting strategies, remains problematic. In this context, we designed and synthesized oligopyridines potentially targeting Mcl-1 hydrophobic pocket, evaluated their capacity to inhibit Mcl-1 in live cells and implemented functional screening assay to evaluate their ability to sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies. We established structure-activity relationships and focused our attention on MR29072, named Pyridoclax. Surface plasmon resonance assay demonstrated that Pyridoclax directly binds to Mcl-1. Without cytotoxic activity as single agent, Pyridoclax induced apoptosis in combination with Bcl xL-targeting siRNA or with ABT-737 in ovarian, lung and mesothelioma cancer cells.






Purchase(buy) Pyridoclax at Active Biochem and the United State(U.S.), Germany, Japan, France,United Kingdom(UK),Switzerland, Australia distributors.